[1]
Papadakis, K. et al. 2025. POT1 genetic testing in melanoma-prone families in Sweden: germline variant prevalence and tumor spectrum in identified carriers. Acta Oncologica. 64, (Aug. 2025), 1102–1108. DOI:https://doi.org/10.2340/1651-226X.2025.44048.